1-hexacosanol has been researched along with Diabetic Nephropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanada, T; Hayashi, A; Kanzaki, S; Kawaba, Y; Kazuyama, E; Okada, S; Saito, M; Satoh, K | 1 |
| Hanada, T; Kinoshita, Y; Kono, T; Saito, M; Satoh, I; Satoh, K; Shinbori, C; Suzuki, H; Uemasu, J; Yamada, M | 1 |
2 other study(ies) available for 1-hexacosanol and Diabetic Nephropathies
| Article | Year |
|---|---|
Effects of N-hexacosanol on nitric oxide synthase system in diabetic rat nephropathy.
Topics: Animals; Diabetic Nephropathies; Fatty Alcohols; Gene Expression Regulation, Enzymologic; Immunoblotting; Kidney; Male; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2008 |
N-hexacosanol ameliorates streptozotocin-induced diabetic rat nephropathy.
Topics: Animals; Blood Urea Nitrogen; Creatinine; Diabetic Nephropathies; Fatty Alcohols; Insulin; Male; Malondialdehyde; Protein Kinase C; Rats; Rats, Sprague-Dawley; Streptozocin; Transforming Growth Factor beta1 | 2006 |